Predicting Factors for Bacteremic Urinary Tract Infection in Community Setting : a Prospective Observational Study
Abstract
Objective: To evaluate the clinical and simple laboratory parameters to predict risk of bacteremia in patients presented with community-acquired UTI.
Material and methods: This prospective observational study was conducted on 106 patients at Nakhonpathom Hospital during December 2014 and August 2015. Inclusion criteria were age ≥ 18 years, fever, presence of at least 1 symptom of UTI, and pyuria. Clinical factors and laboratory data associated with bacteremia were analyzed by multivariable logistic regression.
Result: Sixteen patients (15%) had bacteremia. The probability of bacteremia increased with C-reactive protein level ≥ 20 mg/dl (adjusted OR 10.8; 95%CI: 1.3, 93.4, p= 0.03) and BUN/Cr ratio ≥ 16 (adjusted OR 4.5; 95%CI: 1.1, 18.7, p= 0.04)
Conclusions: C-reactive protein and BUN/Cr ratio are simple, rapid and can be utilized to predict bacteremia in patients presented with community-acquired UTI.
References
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003;49(2):53-70.
3. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000;283(12):1583-90.
4. Velasco M, Martinez JA, Moreno-Martinez A, et al. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis 2003;37(8):1127-30.
5. Van Nieuwkoop C, Bonten TN, van‘t Wout JW, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 2010;14(6):R206.
6. Chan UI, Kim HW, Noh YS, et al. A comparison of the clinical characteristics of elderly and non-elderly women with community onset non obstructive acute pyelonephritis. Korean J Intern Med 2015;30(3):372-83.
7. Lalueza A, Sanz-Trepiana L, Bermejo N, et al. Risk factors for bacteremia in urinary tract infections attended in the emergency department. Intern Emerg Med 2018;13:41-50.
8. Brown P, Ki M, Foxman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Phamacoeconomics 2005;23(11):1123-42.
9. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ 2007;335(7625):879-83.
10. Afshari A, Schrenzel J, leven M, et al. Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection - a new frontier? Crit Care 2012;16(3):222.
11. Grace CJ, Lieberman J, Piece K, et al. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 2001;32(11):1651-5.
12. Hsu CY, Fang HC, Chou KJ, et al. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006;332(4):175-80.
13. Bahagon Y, Raveh D, Schlesinger Y, et al. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis 2007;26(5):349-52.
14. Kofteridis DP, Papadimitraki E, Mantadakis E, et al. Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis. J Am Geriatr Soc 2009;57(11):2125-8.
15. Kim KS, Kim K, Jo YH, et al. A simple model to predict bacteremia in women with acute pyelonephritis. J Infect 2011;63(2):124-30.
16. Chen CY, Chen YH, Lu PL, et al. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcome. J Microbiol Immunol Infect 2012;45(3):228-36.
17. Lee H, Lee YS, Jeong R, et al. Predictive factors of bacteremia in patients with febrile urinary tract infection: an experience at a tertiary care center. Infection 2014;42(4):669-74.
18. Lee CC, Wu CJ, Chi CH, et al. Prediction of community-onset bacteremia among febrile adults visiting an emergency department: rigor matters. Diagn Microbiol Infect Dis 2012;73(2):168-73.
Downloads
Published
How to Cite
Issue
Section
License
ลิขสิทธิ์บทความเป็นของผู้เขียนบทความ แต่หากผลงานของท่านได้รับการพิจารณาตีพิมพ์ลงวารสารแพทย์เขต 4-5 จะคงไว้ซึ่งสิทธิ์ในการตีพิมพ์ครั้งแรกด้วยเหตุที่บทความจะปรากฎในวารสารที่เข้าถึงได้ จึงอนุญาตให้นำบทความในวารสารไปใช้ประโยชน์ได้ในเชิงวิชาการโดยจำเป็นต้องมีการอ้างอิงถึงชื่อวารสารอย่างถูกต้อง แต่ไม่อนุญาตให้นำไปใช้ในเชิงพาณิชย์
